Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Anti-Müllerian Hormone Test: MedlinePlus Lab Test Information

Anti-Müllerian Hormone Test: MedlinePlus Lab Test Information

What is an anti-müllerian hormone (AMH) test?

This test measures the level of anti-müllerian hormone (AMH) in the blood. AMH is made in the reproductive tissues of both males and females. The role of AMH and whether levels are normal depend on your age and gender.

AMH plays an important role in the development of sex organs in an unborn baby. During the first weeks of pregnancy, a baby will start developing reproductive organs. The baby will already have the genes to become either a male (XY genes) or a female (XX genes).

If the baby has male (XY) genes, high levels of AMH are made, along with other male hormones. This prevents the development of female organs and promotes the formation of male organs. If there is not enough AMH to stop the development of female organs, organs of both sexes may form. When this happens, a baby’s genitals may not be clearly identified as male or female. This is known as ambiguous genitalia. Another name for this condition is intersex.

If the unborn baby has female (XX) genes small amounts of AMH are made. This allows for the development of female reproductive organs. AMH has a different role for females after puberty. At that time, the ovaries (glands that make egg cells) begin making AMH. The more egg cells there are, the higher the level of AMH.

In women, AMH levels can provide information about fertility, the ability to get pregnant. The test may also be used to help diagnose menstrual disorders or to monitor the health of women with certain types of ovarian cancer.

Other names: AMH hormone test, müllerian-inhibiting hormone, MIH, müllerian inhibiting factor, MIF, müllerian-inhibiting substance, MIS

What is it used for?

An AMH test is often used to check a woman’s ability to produce eggs that can be fertilized for pregnancy. A woman’s ovaries can make thousands of eggs during her childbearing years. The number declines as a woman gets older. AMH levels help show how many potential egg cells a woman has left. This is known as the ovarian reserve.

If a woman’s ovarian reserve is high, she may have a better chance of getting pregnant. She may also be able to wait months or years before trying to get pregnant. If the ovarian reserve is low, it may mean a woman will have trouble getting pregnant, and should not delay very long before trying to have a baby.

AMH tests may also be used to:

  • Predict the start of menopause, a time in a woman’s life when her menstrual periods have stopped and she can’t become pregnant anymore. It usually starts when a woman is around 50 years old.
  • Find out the reason for early menopause
  • Help find out the reason for amenorrhea, the lack of menstruation. It is most often diagnosed in girls who haven’t started menstruating by the age of 15 and in women who have missed several periods.
  • Help diagnose polycystic ovary syndrome (PCOS), a hormonal disorder that is a common cause of female infertility, the inability to get pregnant
  • Check infants with genitals that are not clearly identified as male or female
  • Monitor women who have certain types of ovarian cancer

Why do I need an AMH test?

You may need an AMH test if you are a woman who is having difficulty getting pregnant. The test can help show what your chances are of conceiving a baby. If you are already seeing a fertility specialist, your doctor may use the test to predict whether you will respond well to treatment, such as in vitro fertilization (IVF).

High levels may mean you may have more eggs available and will respond better to treatment. Low levels of AMH mean you may have fewer eggs available and may not respond well to treatment.

You may also need an AMH test if you are a woman with symptoms of polycystic ovary syndrome (PCOS). These include:

  • Menstrual disorders, including early menopause or amenorrhea
  • Acne
  • Excess body and facial hair growth
  • Decreased breast size
  • Weight gain

In addition, you may need an AMH test if you are being treated for ovarian cancer. The test can help show if your treatment is working.

What happens during an AMH test?

A health care professional will take a blood sample from a vein in your arm, using a small needle. After the needle is inserted, a small amount of blood will be collected into a test tube or vial. You may feel a little sting when the needle goes in or out. This usually takes less than five minutes.

Will I need to do anything to prepare for the test?

You don’t need any special preparations for an AMH test.

Are there any risks to the test?

There is very little risk to having a blood test. You may have slight pain or bruising at the spot where the needle was put in, but most symptoms go away quickly.

What do the results mean?

If you are a woman trying to get pregnant, your results can help show what your chances are for conceiving. It can also help you decide when to try to get pregnant. A high level of AMH can mean your chances are better and you may have more time before trying to get pregnant.

A high level of AMH may also mean you have polycystic ovary syndrome (PCOS). There is no cure for PCOS, but symptoms can be managed with medications and/or lifestyle changes, such as maintaining a healthy diet and waxing or shaving to remove excess body hair.

A low level can mean you may have trouble getting pregnant. It can also mean that you are starting menopause. A low level of AMH is normal in young girls and in women after menopause.

If you are being treated for ovarian cancer, your test can show whether your treatment is working.

In a male infant, a low level of AMH may mean a genetic and/or hormonal problem causing genitals that are not clearly male or female. If AMH levels are normal, it may mean the baby has working testicles, but they are not in the right location. This condition can be treated with surgery and/or hormone therapy.

If you have questions about your results, talk to your health care provider.

Is there anything else I need to know about an AMH test?

If you are a woman being treated for fertility problems, you will probably get other tests, along with AMH. These include tests for estradiol and FSH, two hormones involved in reproduction.

Tagged with:

About author

Related Articles